Ginsenoside Rb1 ameliorates cisplatin-induced learning and memory impairments

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Ginsenoside Rb1 (Rb1) is a key component of Panax ginseng.
• Rb1 demonstrates neuroprotective properties relevant to neurological disorders.

Purpose of the Study:

• To evaluate Rb1's efficacy in mitigating cisplatin-induced memory deficits.
• To elucidate the underlying mechanisms of Rb1's neuroprotective action.

Main Methods:

• Rats received cisplatin (5 mg/kg/wk) and Rb1 (2 mg/kg/d) for 5 weeks.
• Memory was assessed using novel object recognition and Morris water maze tasks.
• Hippocampal neuron counts, oxidative stress markers, cholinergic function, and neuroinflammation were analyzed.

Main Results:

• Rb1 significantly improved memory performance in cisplatin-treated rats.
• Rb1 administration reduced neuronal loss in the hippocampus (CA1, CA3, dentate gyrus).
• Rb1 counteracted cisplatin-induced oxidative stress, neuroinflammation, and cholinergic dysfunction.

Conclusions:

• Rb1 effectively reverses cisplatin-induced memory impairment.
• The mechanism involves reducing oxidative stress and neuroinflammation.
• Rb1 also restores cholinergic neuron function, contributing to memory recovery.